Soluble urokinase receptor released from human carcinoma cells: A plasma parameter for xenograft tumour studies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6690678.pdf
Reference43 articles.
1. Andreasen, PA, Kjøller, L, Christensen, L & Duffy, MJ (1997). The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1–22.
2. Baramova, EN, Bajou, K, Remacle, A, Lhoir, C, Krell, HW, Weidle, UH, Nöel, A & Foidart, JM (1997). Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 405: 157–162.
3. Behrendt, N, Rønne, E, Ploug, M, Petri, T, Løber, D, Nielsen, LS, Schleuning, WD, Blasi, F, Appella, E & Danø, K (1990). The human receptor for urokinase plasminogen activator. NH2-terminal amino acid sequence and glycosylation variants. J Biol Chem 265: 6453–6460.
4. Brünner, N, Thompson, EW, Spang-Thomsen, M, Rygaard, J, Danø, K & Zwiebel, JA (1992). lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur J Cancer 28A: 1989–1995.
5. Chavakis, T, Kanse, SM, Yutzy, B, Lijnen, HR & Preissner, KT (1998). Vitronectin concentrates proteolytic activity on the cell surface and extracellular matrix by trapping soluble urokinase receptor–urokinase complexes. Blood 91: 2305–2312.
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer;JHEP Reports;2020-04
2. Clinical value of soluble urokinase type plasminogen activator receptors in chronic kidney disease;Medicine;2019-09
3. High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma;Carcinogenesis;2019-02-08
4. The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia;Turkish Journal of Hematology;2016-05-17
5. Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Focal Segmental Glomerulosclerosis;Molecular Mechanisms in the Pathogenesis of Idiopathic Nephrotic Syndrome;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3